Non-peptide Opioid Receptor Ligands - Recent Advances. Part II - Antagonists

Author(s): Agnieszka Kaczor, Dariusz Matosiuk

Journal Name: Current Medicinal Chemistry

Volume 9 , Issue 17 , 2002

Become EABM
Become Reviewer
Call for Editor


This paper is the second part of the review on opioid receptor ligands and deals with the progress in the field of non-peptide opioid receptor antagonists (starting from the pioneering opiate studies in the early seventies) with particular stress on the last decade accomplishments. As X-ray high resolution structure determination of the ligand-receptor systems for G protein-coupled receptors meets with considerable experimental obstacles, the knowledge about ligand interactions with the membrane-bound receptors traditionally derives from structure-activity studies. Hence, such a concise summary, collecting chemically distinct but pharmalogically relative compounds, may be a convenient information source for any research concerning ligand-opioid receptor binding or rational drug design.

Keywords: non-peptide opioid receptor, norbinaltorphimine derived ligands, de novo methodology, pharmacophore models, pyrrolomorphinans, kappa opioid receptor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [1591 - 1603]
Pages: 13
DOI: 10.2174/0929867023369358
Price: $65

Article Metrics

PDF: 7